Upregulated Expression of CYBRD1 Predicts Poor Prognosis of Patients with Ovarian Cancer

Figure 3

Gene set enrichment analysis (GSEA) of CYBRD1 in patients with OV from TCGA cohort. GSEA results demonstrating that mucopolysaccharidoses (a), butyrophilin BTN family interaction (b), EGFR/SMRTE pathway (c), IRF3-mediated induction of type I INF (d), FOXO-mediated transcription of cell cycle genes (e), and ERK pathway (f) were differentially enriched in CYBRD1-related EC. ES: enrichment score; NES: normalized ES; NOM value: normalized value.

(a)

(b)

(c)

(d)

(e)

(f)